• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

POZEN, Inc.

NASDAQ:POZN

$6.94 -$0.24 (-3.34%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Investing 101: Undervalued Health Care Stocks Being Bought Up by Hedge Funds

4/12/2012 by DailyFinance

5 of Last Week's Biggest Winners

11/28/2011 by DailyFinance

Pozen Inks $75 Million Royalty Deal for Treximet

11/26/2011 by DailyFinance

Pozen's Digital Marketing Plan: A Prescription for the Pharma Industry?

9/17/2011 by DailyFinance

Acadia Pharmaceuticals: Investing With No Safety Net

6/24/2011 by Minyanville

Pozen Continues Fighting Off Dr. Reddy's Labs

4/26/2011 by Seeking Alpha

Pozen, AstraZeneca Sue Dr Reddy's Over Vimovo Generic

4/25/2011 by Smart Money

Pozen: Injunction Stops Par From Selling Generic Of Pozen Drug

4/15/2011 by Smart Money

FDA Insider Trading: Time for an Overhaul?

3/31/2011 by Seeking Alpha

Pozen's Success Will Depend on Execution of Unique Marketing Strategies

3/13/2011 by Seeking Alpha

What's Pozen Really Worth?

3/8/2011 by Seeking Alpha

Maximizing Opportunity and Minimizing Risk With Trading FDA Decisions

2/8/2011 by Seeking Alpha

Cadence: Patient Investors Should Watch Short Sellers Before FDA Decision on Thursday

11/2/2010 by Seeking Alpha

Pozen CEO Discusses Q3 2010 Results - Earnings Call Transcript

10/30/2010 by Seeking Alpha Transcripts

Pozen CEO Discusses Q3 2010 Results - Earnings Call Transcript

10/30/2010 by Seeking Alpha

AstraZeneca Has European Backing For Arthritis Pain Pill

10/11/2010 by Smart Money

Pfizer's Osteoarthritis Drug Runs Into Unique Roadblock

10/4/2010 by Seeking Alpha

15 Heavily Shorted Stocks Reaching an Inflection Point

8/11/2010 by Seeking Alpha

POZEN Inc Q2 2010 Earnings Call Transcript

8/3/2010 by Seeking Alpha Transcripts

POZEN Inc Q2 2010 Earnings Call Transcript

8/3/2010 by Seeking Alpha

UPDATE: Pozen, AstraZeneca Get FDA Approval For Arthritis Drug

5/3/2010 by Smart Money

Pozen, AstraZeneca Win FDA Approval Of Arthritis Drug -Bloomberg

4/30/2010 by Smart Money

UPDATE 1-Pozen settles migraine drug suit with Teva

4/14/2010 by Reuters

UPDATE 1-Pozen posts narrower-then-expected quarterly loss

3/3/2010 by Reuters